CN105963360A - Drug composition, preparation method and application - Google Patents
Drug composition, preparation method and application Download PDFInfo
- Publication number
- CN105963360A CN105963360A CN201610497685.4A CN201610497685A CN105963360A CN 105963360 A CN105963360 A CN 105963360A CN 201610497685 A CN201610497685 A CN 201610497685A CN 105963360 A CN105963360 A CN 105963360A
- Authority
- CN
- China
- Prior art keywords
- medicine group
- pharmaceutical composition
- fruit
- leaf juice
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug composition which comprises a first drug group, a second drug group and a third drug group. The first drug group is composed of fig leaf, non-fruiting fig leaf and Delonix regia leaf, the second drug group is non-fruiting fig leaf, and the third drug group is composed of fig fruit and pig intestines. The invention further discloses a preparation method and application of the drug composition. The drug composition can be used for treating hemorrhoids and enteritis.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, especially can be used to treat the medicine of hemorrhoid and enteritis
Compositions.
Background technology
Haemorrhoidal vein is positioned at rectum foot and anal region, and edema occur in these positions, make haemorrhoidal vein
Stretching is thinning, and defecation also can stimulate haemorrhoidal vein, when edema vein cause bleeding, pruritus or pain
Time, referred to as hemorrhoid, it is commonly called as hemorrhoid.The cardinal symptom of hemorrhoid is: have blood in stool, pain, abjection, office
Secretions increases, after incarceration anus red and swollen, rotten to the corn, can not sitting and lying, hemorrhoid hemorrhage, be danger
The common sympton that evil is the biggest, is further divided into internal hemorrhoid, external hemorrhoid, mixed hemorrhoid according to happening part.
In general, in the symptom of hemorrhoid, internal hemorrhoid is based on hemorrhage, and external hemorrhoid is the brightest having inflammation when
Aobvious symptom is exactly pain, and mixed hemorrhoid, with two kinds of symptoms, can two kinds of symptoms occur simultaneously,
Can also only have a kind of symptom.
Enteritis is the enteritis that causes such as antibacterial, virus, fungus and parasite and colitis.Face
Bed performance mainly has stomachache, diarrhoea, dilute aquiform stool or mucus bloody purulent stool.Some patients can have heating
And tenesmus sensation, therefore also known as infectious diarrhea.Enteritis is different by course of disease length, is divided into urgency
Property and chronic two classes.The chronic enteritis course of disease is typically more than two months, and clinic common are chronic
Bacillary dysentery, chronic amebic dysentery, nonspecific ulcerative colitis and limit office property enteritis
Deng.
Existing hemorrhoid treating includes taking medicine and operative treatment.Existing medicine, such as
CN101991695A, mostly is the Chinese medicine containing the most tens of kinds of raw materials, its exist complicated component,
The problem that cost is high, and operative treatment exists, and contraindication is many, wound weight, misery are big, it is many to spend
Problem.For treating the Chinese medicine composition of enteritis, such as CN103127439A, exists more
Raw material is complicated, and curative effect is single, the problem that cost is high.
Accordingly, it would be desirable to a kind of new pharmaceutical composition, it can be treated hemorrhoid and enteritis, become simultaneously
Dividing simple, curative effect is obvious.
Summary of the invention
First purpose of the present invention is to provide a kind of pharmaceutical composition.
Second object of the present invention is to provide the preparation method of this pharmaceutical composition.
Third object of the present invention is to provide the application of this pharmaceutical composition.
For realizing above-mentioned first purpose, the present invention uses herein below:
A kind of pharmaceutical composition, including:
First medicine group, is made up of result common fig leaf juice, non-result common fig leaf juice and Delonix regia；
Second medicine group, for not result common fig leaf juice；With
3rd medicine group, is made up of fig fruit and Radix Polygalae Crotalarioidis.
Further, described first medicine group by 70% result common fig leaf juice, 5% not result without
Flowers and fruits leaf and 25% Delonix regia composition.
Further, in described 3rd medicine group, fig fruit is for from blooming 90-95 days beginning
Fig fruit.The usage ratio of Radix Polygalae Crotalarioidis and fig fruit need not limit, can be according to need
Add.
Further, described fig fruit is that tree crown is tall and big, and orthostatic is strong, and tree vigo(u)r is strong,
Branch is few and sturdy, and blade is little, mostly is that palmate 3 is shallow to be split, the shortest oval, really tip circle and slightly
Flat, scale is red, and cervical region is extremely short, and vertical shape fruit rib is more apparent, and peel is thick, reddish violet, sarcocarp
Cerise, taste are sweet, and fragrance is light, and fructescence is the Ficus carica L. in early September to 10 last ten-days period
Fruit.Herein, the leaf of the not the most unseeded Ficus carica L. of result common fig leaf juice；Result
The leaf of common fig leaf juice Ficus carica L. the most fructiferous, needs to select wild Ficus carica L..
In the present invention, the pulverizing mesh of result common fig leaf juice, non-result common fig leaf juice and Delonix regia
Number need not limit, and can pulverize according to need.
For realizing above-mentioned second purpose, the present invention uses herein below:
The preparation method of aforementioned pharmaceutical compositions, including:
Pluck result common fig leaf juice, non-result common fig leaf juice and Delonix regia respectively, respectively too
Tan by the sun under sun, pulverize the most respectively, finally three is mixed, obtain the first medicine group；
Pluck not result, tan by the sun under the sun, pulverize, obtain the second medicine group；
Fig fruit and Radix Polygalae Crotalarioidis are mixed, after steaming or boiling, obtains the 3rd medicine group.
Further, described first medicine group by 70% result common fig leaf juice, 5% not result without
Flowers and fruits leaf and 25% Delonix regia composition.
Further, in described 3rd medicine group, fig fruit is for from blooming 90-95 days beginning
Fig fruit.
Further, described fig fruit is that tree crown is tall and big, and orthostatic is strong, and tree vigo(u)r is strong,
Branch is few and sturdy, and blade is little, mostly is that palmate 3 is shallow to be split, the shortest oval, really tip circle and slightly
Flat, scale is red, and cervical region is extremely short, and vertical shape fruit rib is more apparent, and peel is thick, reddish violet, sarcocarp
Cerise, taste are sweet, and fragrance is light, and fructescence is the Ficus carica L. in early September to 10 last ten-days period
Fruit.
For realizing above-mentioned 3rd purpose, the present invention uses herein below:
The application of aforementioned pharmaceutical compositions, this pharmaceutical composition can be used for treating hemorrhoid and enteritis.
Further, in use, comprise the following steps:
1) the first medicine group boiled water is bubbled open, drink；
2) with step 1) simultaneously, the second medicine group decocting in water is opened, fumigates at anus with steam；
3) after drinking and fumigating a period of time, edible 3rd medicine group.
Further, described step 1) in, use every day 7g the first medicine group to steep 2 diseases caused by retention of fluid
With, 7-10 days/course for the treatment of, totally 3 courses for the treatment of.The water yield, without limiting, can be added according to need.
Further, described step 2) in, use every day the second medicine group to fumigate 1 time, 7-10
My god/course for the treatment of, totally 3 courses for the treatment of.The consumption of the second medicine group without limit, the water yield without limit,
Can add according to need.
Further, described step 3) in, use 20g fig fruit and Radix Polygalae Crotalarioidis every day
Mixed edible.
The invention have the advantages that
The pharmaceutical composition of the present invention is divided into three medicine groups, cooperating by three,
Hemorrhoid and enteritis can be treated the most completely, and do not recurred；
The pharmaceutical composition flavour of a drug of the present invention are few, and preparation is simple, convenient use, evident in efficacy and
Have no side effect.
Detailed description of the invention
In order to be illustrated more clearly that the present invention, below in conjunction with preferred embodiment, the present invention is done into one
The explanation of step.It will be appreciated by those skilled in the art that following specifically described content is explanation
Property and nonrestrictive, should not limit the scope of the invention with this.
Embodiment
One, the pharmaceutical composition of the present invention is prepared
1, the first medicine group
1) composition: common fig leaf juice: 75% (wherein, result common fig leaf juice 70%+ not result
Common fig leaf juice 5%)；Delonix regia: 25%.
2) prepare: harvesting → dry in the sun (sun tans by the sun) → pulverizing → mixing.
2, the second medicine group
1) composition: common fig leaf juice: 100% (not result common fig leaf juice)
2) prepare: harvesting → dry in the sun (sun tans by the sun) → pulverizing.
3, the 3rd medicine group
1) composition :+Radix Polygalae Crotalarioidis is (no for fig fruit (fruit started 90-95 days of blooming)
Limit consumption).
2) prepare: steam or boil.
Result common fig leaf juice, non-result common fig leaf juice and Delonix regia are the leaf of wild tree.
Fig fruit is that tree crown is tall and big, and orthostatic is strong, and tree vigo(u)r is strong, and branch is few and sturdy, blade
Little, mostly be that palmate 3 is shallow to be split, the shortest oval, really tip circle and the most flat, scale is red, cervical region
Extremely short, vertical shape fruit rib is more apparent, and peel is thick, and reddish violet, sarcocarp cerise, taste are sweet, fragrance
Light, fructescence is the fruit of the caprifig tree in early September to 10 last ten-days period.
Two, experiment
Select altogether 100 hemorrhoid patients (internal hemorrhoid 50 people, external hemorrhoid 30 people, mixed hemorrhoid 20 people),
50 patients having chronic intestinal inflammation.
The use step of the pharmaceutical composition of the present invention: take 7g the first medicine group every day, with opening
Blister 2 times, the water yield does not limits, and drinks.Meanwhile, take 50g the second medicine group every day, add decocting in water
Opening, fumigate with steam, the water yield does not limits, and smokes 1 every day.Both uses 10 days/treatment simultaneously
Journey, totally 3 courses for the treatment of.Afterwards, take 20g fig fruit every day and mix with Radix Polygalae Crotalarioidis, steam or
After boiling, edible decoction and residue, continue 7 days.
100 hemorrhoid patients of reselection are matched group.Wherein, in matched group one, 50 people use
Commercially available diyu huaijiao pills (Beijing Tongrentang), by specification uses；In matched group two, 50
People uses anus Thailand of medicine for external use Rongchang County ZHICHUANG GAO (pharmacy of Yantai Rongchang County), and by specification uses.
Three, efficacy assessment standard:
Cure: Clinical symptom and sign disappears, recover normal, and without recurrence in half a year.
Effective: clinical symptoms is clearly better.
Invalid: Clinical symptom and sign is without improving.
Four, therapeutic outcome
Internal hemorrhoid patient 48 people using the pharmaceutical composition of the present invention cures, and 2 people are effective；External hemorrhoid
Patient 27 people cures, and 3 people are effective；Mixed hemorrhoid patient 19 people cures, and 1 people is effective；Chronic
Enteritis patient 46 people cures, and 4 people are effective.In matched group one, 35 people cure, and 10 people are effective,
5 people are invalid.In matched group two, 40 people cure, and 8 people are effective, and 2 people are invalid.
Visible, the pharmaceutical composition flavour of a drug of the present invention are few, and preparation is simple, is divided into three medicines
Group, cooperating by three, hemorrhoid and enteritis can have been treated the most completely,
And do not recur.
Obviously, the above embodiment of the present invention is only by clearly demonstrating the act that the present invention is made
Example, and it is not the restriction to embodiments of the present invention, for the ordinary skill of art
For personnel, change or the change of other multi-form can also be made on the basis of the above description
Dynamic, cannot all of embodiment be given exhaustive here, every technical side belonging to the present invention
What case was extended out obviously changes or changes the row still in protection scope of the present invention.
Claims (10)
1. a pharmaceutical composition, it is characterised in that including:
First medicine group, is made up of result common fig leaf juice, non-result common fig leaf juice and Delonix regia；
Second medicine group, for not result common fig leaf juice；With
3rd medicine group, is made up of fig fruit and Radix Polygalae Crotalarioidis.
A kind of pharmaceutical composition the most according to claim 1, it is characterised in that described
First medicine group is by 70% result common fig leaf juice, 5% not result common fig leaf juice and 25% Ramulus et Folium Delonicis regiae
Leaf forms.
A kind of pharmaceutical composition the most according to claim 1, it is characterised in that described
In 3rd medicine group, fig fruit is the fig fruit from the 90-95 days beginning of blooming.
A kind of pharmaceutical composition the most according to claim 1, it is characterised in that described
Fig fruit is that tree crown is tall and big, and orthostatic is strong, and tree vigo(u)r is strong, and branch is few and sturdy, blade
Little, mostly be that palmate 3 is shallow to be split, the shortest oval, really tip circle and the most flat, scale is red, cervical region
Extremely short, vertical shape fruit rib is more apparent, and peel is thick, and reddish violet, sarcocarp cerise, taste are sweet, fragrance
Light, fructescence is early September to the fruit of the Ficus carica L. in 10 last ten-days period.
5. the preparation method of a kind of pharmaceutical composition as described in claim 1-4 is arbitrary, it is special
Levy and be, including:
Pluck result common fig leaf juice, non-result common fig leaf juice and Delonix regia respectively, respectively too
Tan by the sun under sun, pulverize the most respectively, finally three is mixed, obtain the first medicine group；
Pluck not result, tan by the sun under the sun, pulverize, obtain the second medicine group；
Fig fruit and Radix Polygalae Crotalarioidis are mixed, after steaming or boiling, obtains the 3rd medicine group.
6. the application of a kind of pharmaceutical composition as described in claim 1-4 is arbitrary, described medicine
Compositions can be used for treating hemorrhoid and enteritis.
The application of a kind of pharmaceutical composition the most according to claim 6, it is characterised in that
In use, comprise the following steps:
1) the first medicine group boiled water is bubbled open, drink；
2) with step 1) simultaneously, the second medicine group decocting in water is opened, fumigates at anus with steam；
3) after drinking and fumigating a period of time, edible 3rd medicine group.
The application of a kind of pharmaceutical composition the most according to claim 7, it is characterised in that
Described step 1) in, use every day 7g the first medicine group steep 2 diseases caused by retention of fluid use, 7-10 days/
The course for the treatment of, totally 3 courses for the treatment of.
The application of a kind of pharmaceutical composition the most according to claim 7, it is characterised in that
Described step 2) in, use every day the second medicine group to fumigate 1 time, 7-10 days/course for the treatment of, totally 3
The individual course for the treatment of.
The application of a kind of pharmaceutical composition the most according to claim 7, it is characterised in that
Described step 3) in, use 20g fig fruit and Radix Polygalae Crotalarioidis mixed edible every day.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610497685.4A CN105963360A (en) | 2016-06-29 | 2016-06-29 | Drug composition, preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610497685.4A CN105963360A (en) | 2016-06-29 | 2016-06-29 | Drug composition, preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105963360A true CN105963360A (en) | 2016-09-28 |
Family
ID=57020337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610497685.4A Pending CN105963360A (en) | 2016-06-29 | 2016-06-29 | Drug composition, preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105963360A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108576325A (en) * | 2018-05-26 | 2018-09-28 | 贵州江口骆象茶业有限公司 | A kind of function tea for treating enteritis |
| CN109432221A (en) * | 2018-11-20 | 2019-03-08 | 熊明彬 | A kind of Chinese medicinal formulae for treating hemorrhoid |
-
2016
- 2016-06-29 CN CN201610497685.4A patent/CN105963360A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| 刘弘等: "无花果叶的化学及药理研究进展 ", 《华夏医学》 * |
| 王水龙: "《食物养生宜忌与祛病偏方》", 30 November 2015, 西安交通大学出版社 * |
| 邓增慧: "无花果炖猪大肠治内痔效果好 ", 《四川农业科技》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108576325A (en) * | 2018-05-26 | 2018-09-28 | 贵州江口骆象茶业有限公司 | A kind of function tea for treating enteritis |
| CN109432221A (en) * | 2018-11-20 | 2019-03-08 | 熊明彬 | A kind of Chinese medicinal formulae for treating hemorrhoid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ody | The complete medicinal herbal: a practical guide to the healing properties of herbs | |
| Gami | Hemorrhoids-a common ailment among adults, causes & treatment: a review | |
| Ardalani et al. | The Effect of Cynara scolymus on blood pressure and BMI in hypertensive patients: A randomized, double-blind, placebo-controlled, clinical trial | |
| CN102370756A (en) | Chinese patent drug and Chinese medicine decoction capable of effectively curing intestinal cancer, liver cancer, uterine cancer and stomach cancer | |
| Lev et al. | European and Oriental mistletoe: From mythology to contemporary integrative cancer care | |
| CN101829278B (en) | Quick antiphlogistic and analgesic Chinese herbal preparation | |
| CN105963360A (en) | Drug composition, preparation method and application | |
| CN104383412A (en) | Depression-resolving health traditional Chinese medicine liquor and preparation method thereof | |
| CN108014183A (en) | A kind of medicine for treating burns, scald, trauma | |
| CN104524481B (en) | A kind of Chinese medicine for treating IBS and preparation method thereof | |
| CN103977390B (en) | A kind of preparation method and its usage of ginger onion medicated wine composition | |
| CN107080240B (en) | A kind of health food conditioner for alleviating qi depression to blood stasis and preparation method thereof | |
| CN109420089A (en) | A kind of Chinese medicinal formulae for improving and preventing for the proliferation of mammary gland | |
| CN104324081A (en) | Corydalis tuber superfine powder and preparation method and application thereof | |
| CN104107264A (en) | Traditional Chinese medicine agent for treating infantile constipation and preparation method and application of traditional Chinese medicine agent | |
| CN101360430B (en) | Functional food composition for treating allergy, natural tea using the same and the manufacturing method thereof | |
| CN103520331B (en) | Traditional Chinese medicinal preparation for treating liver-stomach disharmony type chronic gastritis and preparation method for traditional Chinese medicinal preparation | |
| CN104042646B (en) | A kind of acne cream and preparation method thereof | |
| CN104383283B (en) | Treat enteritis, the oral drugs of dysentery | |
| CN104352802A (en) | Traditional Chinese medicine composition for treating chronic dysentery and preparation method thereof | |
| CN101816708B (en) | Chinese medicinal composition for curing rheumatism and preparation method thereof | |
| CN104758358A (en) | Medicine composite used for eczema and preparation method thereof | |
| CN101104066B (en) | Traditional Chinese medicine composition for treating cold syndrome of disease of acid regurgitation | |
| KR20040036278A (en) | Extracts derived from Chinese medicines for preventive measures and the incontinence of urine and manufacturing thereof | |
| Hasan et al. | The incredible health benefits of saffron: a review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160928 |